Conference Scene: Summary report from EAACI: London 2010.
Immunotherapy is, to date, the only effective curative method for the treatment of allergic disorders. Great efforts have been made to improve the efficacy, safety and patient compliance with this method. The growing understanding of the immunological mechanisms underlying immunotherapy has led to new approaches for immunotherapy involving the routes of administration and the kinds of molecules used. In addition, new vaccines are being created that combine the advantageous immunological charasteristics of different substances, such as virus-like particles linked to allergens. Many new results from ongoing research into these topics were presented at the 29th congress of the European Academy of Allergy and Clinical Immunology in London.
Stiehm
Matthias
M
Bufe
Albrecht
A
D000485:Allergens / Q000276:immunology*; D000486:Allergy and Immunology; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D008131:London; D010349:Patient Compliance; D012958:Societies, Scientific; D058425:Vaccines, Virus-Like Particle
D000485:Allergens; D058425:Vaccines, Virus-Like Particle